We found that Adriamycin-resistant breast cancer cell line MCF7/ADR not only had lower levels of miR-148a expression, but also higher levels of PDK1 expression compared to the control (MCF7) (Figure S4A,B). The gene discussed is PDK1; the disease is breast carcinoma.